RMD - ResMed Inc logo

ResMed Inc

RMD
8.9/10top 1%Revenue grew 100% of years20Y
Compare RMD Hold

ResMed Inc. develops and manufactures medical devices and cloud-based software for diagnosing and managing respiratory disorders, focusing on sleep apnea solutions and healthcare software for home medical equipment providers and agencies.

⚕️ Healthcare NYSE Listed 1995 $ USD
$1,000 invested 30 years ago →$276,409today

Score Overview

1 Year
Score
Net Growth4.59%
Net TrendGrew
Net Income Consistency—
Rev Growth1.40%
Rev TrendGrew
Revenue Consistency—
5 Years
Score8.9
Net Growth104.40%
Net TrendEvery year
Net Income Consistency—
Rev Growth60.21%
Rev TrendEvery year
Revenue Consistency—
10 Years
Score
Net Growth365.45%
Net Trend80%
Net Income Consistency
Rev Growth177.38%
Rev TrendEvery year
Revenue Consistency
20 Years
Score8.9
Net Growth24x
Net Trend80%
Net Income Consistency
Rev Growth8x
Rev TrendEvery year
Revenue Consistency
30 Years
Score
Net Growth212x
Net Trend80%
Net Income Consistency
Rev Growth116x
Rev TrendEvery year
Revenue Consistency
All Time
Score
Net Growth568x
Net Trend81%
Net Income Consistency
Rev Growth243x
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking →

Where ResMed Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Reached the top 50 on HDB Score in 9 years, the longest run being 7 in a row — but not in 2021.

  • RMD

2006: 3.4% · 2021: 10.3% · free through 2021 · longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 237.85—
1 Year2025-11-17
$ 242.05-1.74%
5 Years2021-11-17
$ 250.58-5.08%
10 Years2016-11-17
$ 52.78350.63%
20 Years2006-11-17
$ 20.3411x
30 Years1996-11-15
$ 0.86276x
All Time1995-06-02
$ 0.55430x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 5.73B$ 1.59B$ 1.01B
2026$ 5.65B$ 1.52B$ 1.46B
2025$ 5.14B$ 1.40B$ 1.20B
2024$ 4.68B$ 1.02B$ 238M
2023$ 4.22B$ 897M$ 227M
2022$ 3.57B$ 779M$ 273M
2021$ 3.19B$ 474M$ 295M
2020$ 2.95B$ 621M$ 463M
2019$ 2.60B$ 404M$ 147M
2018$ 2.34B$ 315M$ 188M
2017$ 2.06B$ 342M$ 821M
2016$ 1.83B$ 352M$ 731M
2015$ 1.67B$ 352M$ 717M
2014$ 1.55B$ 345M$ 905M
2013$ 1.51B$ 307M$ 876M
2012$ 1.36B$ 254M$ 809M
2011$ 1.24B$ 226M$ 735M
2010$ 1.09B$ 190M$ 488M
2009$ 920M$ 146M$ 415M
2008$ 835M$ 110M$ 321M
2007$ 716M$ 66M$ 277M
2006$ 606M$ 88M$ 219M
2005$ 425M$ 64M$ 142M
2004$ 339M$ 57M$ 140M
2003$ 273M$ 45M$ 121M
2002$ 204M$ 37M$ 92M
2001$ 155M$ 11M$ 102M
2000$ 115M$ 22M$ 21M
1999$ 88M$ 16M$ 16M
1998$ 66M$ 10M$ 15M
1997$ 49M$ 7M$ 9M
1996$ 34M$ 4M$ 5M
IPO1995$ 23M$ 2M$ 3M
RMD - ResMed Inc logo

ResMed Inc fundamental performance

Between 2006 and 2026, revenue grew from $ 606M to $ 5.65B and net income grew from $ 88M to $ 1.52B. Revenue increased in every one of those 20 years; net income in 16.

Across ResMed Inc's full reported history, from 1995 to 2026, revenue grew from $ 23M to $ 5.65B and net income grew from $ 2M to $ 1.52B. Revenue increased in 100% of the years measured; net income in 81%.

ResMed Inc currently holds a 20-year HDB Score of 8.9 out of 10. How the HDB Score is calculated.

Membership

Continue RMD’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,187 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies